降低功能和左心房扩张作为预测器的事件心房动在患有多变性心肌病的患者
Yuriko Tsumaya1, Kenshi Hayashi2,3, Toyonobu Tsuda2
1Department of Clinical Laboratory Kanazawa University Hospital Kanazawa Japan.
Journal of arrhythmia
|November 28, 2025
概括
降低功能和更大的左心房大小预测高性心肌病 (HCM) 患者的新发性心房动 (AF). 早期检测和监测对于这个高风险群体至关重要.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 临床研究 临床研究
背景情况:
- 心房动 (AF) 在高性心肌病 (HCM) 中很常见,增加风险.
- 慢性病 (CKD) 是心血管风险因素,但其与HCM新发性AF的联系尚不清楚.
- 估计的膜过率 (eGFR) 是功能的一个关键指标.
研究的目的:
- 为了确定HCM患者新发性AF的发病率.
- 确定新发性AF的预测因子,重点关注功能和左心房大小.
主要方法:
- 分析了198名没有先前AF的HCM患者.
- 评估了功能 (eGFR) 和左心房直径 (LAD).
- 考克斯的比例危险建模确定了AF的预测因素.
主要成果:
- 17.7%的患者患有功能受损 (eGFR < 60).
- 在7.5年的时间里,21.7%的患者出现了新发的肌肉前 (发病率为2.8/100人/年).
- 减少eGFR和增加LAD是AF的独立预测因素.
结论:
- 降低功能和左心房扩大与HCM中新发性AF有关.
- HCM患者需要更密切的监测,以检测AF.
- 识别这些风险因素有助于管理HCM中AF风险.
更多相关视频
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
374
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
374
Heart Failure II: Pathophysiology
685
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
685
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
382
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
382
Mitral Regurgitation I: Introduction
381
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
381
Cardiomyopathy V: Interprofessional Care
314
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
314
Rheumatic Heart Disease I: Introduction
408
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
408


